FT Appeal for Alzheimer’s research

Alzheimer’s is a devastating disease, affecting nearly 50m people across the world.

Alzheimer’s Research UK is at the forefront of the fight to find a breakthrough for better treatments. Through the FT’s Seasonal Appeal you can support their pioneering work.

A matching scheme for donations up to a total of £300,000 has been generously provided by Goldman Sachs.

Donate

Burden falls on loved ones in country where few patients receive diagnosis or treatment

Poll finds majority believe a diagnosis would be helpful even if no treatment is available

Eight people discuss what it is like to live or care for someone with Alzheimer’s

Rapidly ageing population prompts move to make care part of community life

Former PM on why he joined the fight against Alzheimer’s and how the UK can help find a cure

We’ve all heard of dementia — but how does it feel? Read stories about living with the disease

More from this Series

Routes are opening up potentially to prevent or reverse damage that leads to the disease

Our Seasonal Appeal stories will combine the best of the FT’s science and international reporting along with personal stories from FT writers

A new movement aims to break the silence over a little-understood disease

How scientists and game designers are fighting the disease

Five FT writers share their personal stories of how dementia has affected their family

There are just 4 drugs to treat symptoms of a disease that affects 44m people worldwide

An explainer on the most common cause of dementia and whether there is a cure